1. Bang OY, Fujimura M, Kim SK. The pathophysiology of moyamoya disease: an update. J Stroke. 2016; 18:12–20.
Article
2. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011; 6:e22542.
3. Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. Importance of
RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016; 124:1221–1227.
Article
4. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G>A variant of
RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012; 78:803–810.
Article
5. Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016; 18:2–11.
Article
6. Ge P, Ye X, Liu X, Deng X, Wang R, Zhang Y, et al. Association between p. R4810K variant and long-term clinical outcome in patients with moyamoya disease. Front Neurol. 2019; 10:662.
7. Nomura S, Yamaguchi K, Akagawa H, Kawashima A, Moteki Y, Ishikawa T, et al. Genotype-phenotype correlation in long-term cohort of Japanese patients with moyamoya disease. Cerebrovasc Dis. 2019; 47:105–111.
Article
8. Kim WH, Kim SD, Nam MH, Jung JM, Jin SW, Ha SK, et al. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the
RNF213 polymorphism. Childs Nerv Syst. 2019; 35:309–314.
Article
9. Kawabori M, Ito M, Kazumata K, Tokairin K, Hatanaka KC, Ishikawa S, et al. Impact of
RNF213 c.14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease. Cerebrovasc Dis. 2022; Sep. 5. [Epub].
https://doi.org/10.1159/000526089.
Article
10. Wen J, Sun X, Chen H, Liu H, Lai R, Li J, et al. Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res. 2016; 1644:70–78.
Article